Product Information

ENTECAVIR 0.5 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.2423 per EA under NDC 16714071701. Its NADAC has been published 446 times since May 9, 2018.

FDA first approved this application on Dec 6, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENTECAVIR 0.5 MG TABLET

ENTECAVIR
$0.2423per EA

Strength

.5 mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714071701

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ENTECAVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA206872

FDA Approved

12/6/2016

TE Code

AB

On Market Since

6/15/2017

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for ENTECAVIR 0.5 MG TABLET has been published 446 times since May 9, 2018, and over the history we have for it it has declined 92.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2423 per EA
All-time high$3.3083 (May 16, 2018)
All-time low$0.2096 (May 20, 2026)
52-week high$0.2460
52-week low$0.2096
Median price$0.7269
Average price$0.9281
Largest weekly change+48.1% (Jul 17, 2024)
Weeks tracked446
Tracking sinceMay 9, 2018

Price History

1W

-1.5%

1M

+10.8%

3M

+13.5%

6M

+15.6%

1Y

+3.3%

3Y

-50.8%

5Y

-74.7%

All

-92.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ENTECAVIR 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by NorthStar Rx LLC, is $0.2423 per EA (NDC 16714071701), effective Nov 18, 2026.

How has the price of ENTECAVIR 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 92.7%. It has been tracked across 446 weekly CMS publications since May 9, 2018.

What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?

Since May 9, 2018, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $0.2096 (May 20, 2026) to a high of $3.3083 (May 16, 2018), with a median of $0.7269 per EA.

Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENTECAVIR 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ENTECAVIR 0.5 MG TABLET?

ENTECAVIR 0.5 MG TABLET (NDC 16714071701) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.